Baylor Genetics

Baylor Genetics Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at

Baylor Genetics is founded in academics and driven by discovery; we are dedicated to delivering comprehensive answers to the toughest genetic questions.

We’re at the 20th Annual Virginia State Genetics Education Conference and look forward to connecting with the genetic co...
04/24/2026

We’re at the 20th Annual Virginia State Genetics Education Conference and look forward to connecting with the genetic counseling community.

Stop by our booth to meet the team and learn how Baylor Genetics’ enhanced Whole Genome Sequencing, now including optical genome mapping, long‑read sequencing, and RNA Sequencing when deeper analysis is needed, delivers insights beyond standard sequencing.

Learn more: https://www.baylorgenetics.com/

04/20/2026

Behind every test result is a laboratory team making precision diagnostics possible.

Fan Xia, Chief Genomics Officer at Baylor Genetics, shares how our laboratory teams play a central role in advancing precision diagnostics by supporting providers with high‑quality data, helping patients move closer to answers, and partnering across the healthcare ecosystem to push genomic science forward.

The continuous innovation happening in our labs is foundational to delivering reliable insights that clinicians and patients depend on.

Watch the video to hear why our lab teams are at the heart of everything we do, and why their work matters now more than ever.

Hello from St. Paul, Minnesota!We’re at the Minnesota Genetic Counselors Association (MNGCA) Spring Education Conference...
04/17/2026

Hello from St. Paul, Minnesota!

We’re at the Minnesota Genetic Counselors Association (MNGCA) Spring Education Conference and look forward to connecting with the genetic counseling community.

Stop by our booth to meet the team and learn how Baylor Genetics' Whole Genome Sequencing, enhanced with optical genome mapping, long-read sequencing, and RNA sequencing, is helping providers gain deeper insight into complex cases, reduce uncertainty, and support more informed care decisions for patients.

Learn more about how Baylor Genetics supports informed, patient-centered care through comprehensive genomic insights: https://www.baylorgenetics.com/

Baylor Genetics is seeking a Senior Specimen Management Specialist to oversee the handling, processing, and tracking of ...
04/17/2026

Baylor Genetics is seeking a Senior Specimen Management Specialist to oversee the handling, processing, and tracking of biological samples across our laboratory operations.

In this role, you will ensure specimens are managed with precision and care while maintaining compliance with regulatory standards. You will also mentor team members and collaborate across functions to resolve complex challenges and improve workflows.

If you are ready to make an impact behind the scenes of genetic testing, we encourage you to join our team!

Apply now: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=f3804318-f10e-4797-af6a-834b14ea1077

04/14/2026

Some diagnoses require more than a standard diagnostic approach.

Rob Rigobello, MS, CGC, Senior Manager of Medical Affairs, discusses how Baylor Genetics’ Whole Genome Sequencing (WGS) can help uncover clinically meaningful findings that standard approaches may miss. Our WGS test, which now includes long‑read sequencing and optical genome mapping, supports key enhancements to analysis, including:

- Enhanced short tandem repeat (STR) analysis, increasing coverage from 29 to 58 genes with STRs associated with neurological, neuromuscular, and other conditions
- Methylation analysis to detect FMR1 methylation status for Fragile X syndrome
- Complex structural variant analysis to augment detection and improve interpretation of potential rearrangements identified through standard WGS

Learn how we’re unlocking the power of genomics to enable faster, more accurate diagnoses: www.baylorgenetics.com

Rare disease diagnosis is often limited by the blind spots of single‑method genomic testing. While genome sequencing pro...
04/13/2026

Rare disease diagnosis is often limited by the blind spots of single‑method genomic testing. While genome sequencing provides a diagnosis for a substantial percentage of patients, gaps persist due to short‑read sequencing coverage, the lack of other omics, and the continuous discovery of new gene-disease associations.

In this ACMG Exhibit Theatre presentation, Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer, and Chris Sands, Chief Growth Officer, highlight how Baylor Genetics’ enhanced Whole Genome Sequencing platform expands clinical insights by incorporating multimodal data and integrated multiomic solutions. This approach strengthens diagnostic yield and provides more actionable information to guide patient care and outcomes.

Watch it here to learn more: https://youtu.be/F9bPmqtSPos

Patients deserve more than data. They deserve clear, actionable answers.For nearly 50 years, Baylor Genetics has focused...
04/09/2026

Patients deserve more than data. They deserve clear, actionable answers.

For nearly 50 years, Baylor Genetics has focused on one mission: to empower patients, healthcare providers, and partners with trusted insights.

We use the most advanced genetic tests to deliver answers that change lives. Our comprehensive tests—paired with unmatched expert interpretation—deliver deeper insights across rare disease, pediatrics, reproductive health, hereditary cancer, metabolic disorders, and more.

Explore how Baylor Genetics is advancing precision diagnostics: www.baylorgenetics.com

When answers matter, testing should do more.Baylor Genetics’ enhanced Whole Genome Sequencing—with optical genome mappin...
04/07/2026

When answers matter, testing should do more.

Baylor Genetics’ enhanced Whole Genome Sequencing—with optical genome mapping, long‑read sequencing, and RNA Sequencing automatically reflexed when deeper analysis is needed—delivers deeper insight when standard sequencing isn’t enough.

What this adds:
- Expanded STR analysis (29 → 58 genes)
- FMR1 methylation analysis for Fragile X
- Improved detection of complex structural variants

By integrating multiple genomic modalities, our WGS platform is designed to uncover clinically meaningful answers, especially for patients with unresolved features and progressive neurologic symptoms.

Learn more: https://www.baylorgenetics.com/wgs2026/

Baylor Genetics is seeking a Senior Manager, Pricing & Contracting to support the expansion of our market access and pay...
04/03/2026

Baylor Genetics is seeking a Senior Manager, Pricing & Contracting to support the expansion of our market access and payer engagement strategy.

In this role, you’ll partner with cross-functionally to evaluate contract terms, develop pricing models, and generate insights that support coverage and reimbursement for genetic testing.

Your work will help drive informed decisions that expand patient access and strengthen payer relationships.

If you’re ready to help advance access to genetic insights, we encourage you to join our team! Apply today: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=c9675490-6774-4233-a411-e6cb8b48dfb1

04/02/2026

As genomic testing guidelines continue to evolve, so does our understanding of who can benefit—and when.

In this video, Leah Campbell, Medical Science Liaison, and Sydney Lau, Sr. Clinical Science Liaison of Baylor Genetics, discuss the growing importance of adult sequencing and what it means as pediatric patients age into adulthood. They explore how expanded access to genomic testing can deepen understanding of disease over time, inform long‑term care, and support more informed decision‑making.

By learning from adult patients, the genetics community can better understand how conditions evolve—and how care may need to adapt as patients grow older.

Watch the video to hear why adult sequencing is an important part of advancing precision diagnostics across the lifespan.

Meet Scott Jeffers, Chief Operating Officer at Baylor Genetics. With more than 30 years of healthcare and diagnostics le...
03/31/2026

Meet Scott Jeffers, Chief Operating Officer at Baylor Genetics. With more than 30 years of healthcare and diagnostics leadership, Scott oversees the operational foundations that power our growth, from service performance and scalability to the systems and teams that enable innovation to reach providers and patients.

Scott’s experience leading large, complex organizations across diagnostics, manufacturing, and healthcare helps ensure we scale with intention, efficiency, and impact, so our science can make a difference where it matters most.

Learn more about our mission to deliver answers that matter: www.baylorgenetics.com

We recently announced enhancements to our Whole Genome Sequencing (WGS) test with the addition of optical genome mapping...
03/24/2026

We recently announced enhancements to our Whole Genome Sequencing (WGS) test with the addition of optical genome mapping and long‑read sequencing as supplemental technologies.

These advanced technologies, along with RNA Sequencing, enable Baylor Genetics’ WGS test to go beyond standard sequencing approaches, providing a more precise view of a patient’s genome and delivering more answers to help guide patient care and outcomes. As of today, March 24, these enhanced WGS capabilities are commercially available.

This Friday, March 27, Baylor Genetics will be onsite at two upcoming conferences:
- Pennsylvania Association of Genetic Counselors Annual Conference in Harrisburg, PA
- Georgia Association of Genetic Counselors Annual Education Conference in Atlanta, GA

We’ll have a table at each event, where teammates will be available to discuss how our enhanced WGS can provide help shorten the diagnostic odyssey. Learn more: https://www.baylorgenetics.com/news/baylor-genetics-connects-with-genetic-counselors-to-advance-answers-in-rare-and-undiagnosed-disease/

Address

2450 Holcombe Boulevard
Houston, TX
77021

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm
Saturday 8am - 6pm

Telephone

+18004114363

Website

Alerts

Be the first to know and let us send you an email when Baylor Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category

Our Story

Baylor Genetics is a joint venture of Miraca Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care.

Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.